Windtree Therapeutics (NASDAQ:WINT – Get Free Report) released its quarterly earnings results on Monday. The company reported ($20.91) EPS for the quarter, missing the consensus estimate of ($8.11) by ($12.80), Zacks reports.
Windtree Therapeutics Trading Up 1.9 %
Shares of NASDAQ WINT opened at $11.43 on Wednesday. The firm’s 50-day moving average is $5.81 and its 200-day moving average is $5.71. The firm has a market capitalization of $6.77 million, a PE ratio of -0.31 and a beta of 0.55. Windtree Therapeutics has a 1 year low of $2.81 and a 1 year high of $27.00.
About Windtree Therapeutics
Further Reading
- Five stocks we like better than Windtree Therapeutics
- Dividend Capture Strategy: What You Need to Know
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
- Upcoming IPO Stock Lockup Period, Explained
- Traditional IRA vs. Roth IRA vs. 401(k): A Comparison
- What is a Special Dividend?
- Is AMD Closing the Gap with Nvidia After its Recent Acquisition?
Receive News & Ratings for Windtree Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Windtree Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.